Phase II study of cyclophosphamide, interferon-alpha and betamethasone (CIB) as induction therapy for patients 60-75 years of age with multiple myeloma stages II and III. (Q44519502)
Jump to navigation
Jump to search
scientific article published in January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of cyclophosphamide, interferon-alpha and betamethasone (CIB) as induction therapy for patients 60-75 years of age with multiple myeloma stages II and III. |
scientific article published in January 2003 |
Statements
1 reference
Phase II study of cyclophosphamide, interferon-alpha and betamethasone (CIB) as induction therapy for patients 60-75 years of age with multiple myeloma stages II and III. (English)
1 reference
Jeanette Lundin
1 reference
Anders Osterborg
1 reference
Magnus Björkholm
1 reference
Bo Björkstrand
1 reference
Fredrik Celsing
1 reference
Viktoria Hjalmar
1 reference
Olle Linder
1 reference
Michaela Luthman
1 reference
Mats Merup
1 reference
Ulf Tidefelt
1 reference
Hakan Mellstedt
1 reference
Myeloma Group of Central Sweden
1 reference
1 January 2003
1 reference
1 reference
Identifiers
1 reference